Status:
COMPLETED
Physical Activity Intervention for Lung Cancer Survivors
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
Fox Chase Cancer Center
University of Alberta
Conditions:
Lung Cancer
Survivor
Eligibility:
All Genders
21+ years
Brief Summary
The purpose of this study is to learn how many lung cancer survivors will agree to a physical activity program. We also want to know if lung cancer survivors benefit from this program. This informatio...
Eligibility Criteria
Inclusion
- Diagnosis and treatment at MSKCC of primary NSCLC; and/or pulmonary carcinoid;
- At least one year post thoracic surgical resection;
- Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
- Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
- Able to complete a six-minute walk test (6MWT);
- Able to provide informed consent.
- FOCUS GROUP ONLY:
- • Completed the Physical Activity program offered through this study (08067);
Exclusion
- Presence of one of the following medical factors at screening:
- regular use of an ambulatory aid (cane or walker);
- resting oxygen saturation less than 88%;
- inability to walk due to severe arthritis or other musculoskeletal problems;
- a diagnosis of unstable angina in the previous 6 weeks;
- a heart attack, angioplasty or heart surgery in the previous 3 months;
- current heart rate \<50 or \>120 at rest; current uncontrolled hypertension;
- current significant valvular heart disease or decompensated congestive heart failure and
- patient reported pain of any origin that would preclude participation in the proposed PA intervention
- Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
- Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
- Patient resides at more than two hours travel distance from the Center
- Insufficient English fluency to complete evaluation tools.
Key Trial Info
Start Date :
June 10 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 5 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00717795
Start Date
June 10 2008
End Date
June 5 2023
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065